Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review

References

• Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, Abu-Elmagd K, Marsh W, Madariaga J, Mazariegos G, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232:490-500; PMID:10998647; http://dx.doi.org/10.1097/00000658-200010000-00004
   PubMed Web of Science ®Google Scholar
• Organ Procurement and Transplantation Network.
   Google Scholar
• Center for International Blood & Marrow Transplant Research.
   Google Scholar
• Danziger-Isakov L, Kumar D, Practice ASTIDCo. Vaccination in solid organ transplantation. Am J Transplant 2013; 13 Suppl 4:311-7; PMID:23465023; http://dx.doi.org/10.1111/ajt.12122
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:309-18; PMID:24421306; http://dx.doi.org/10.1093/cid/cit816
   PubMed Web of Science ®Google Scholar
• Kano H, Mizuta K, Sakakihara Y, Kato H, Miki Y, Shibuya N, Saito M, Narita M, Kawarasaki H, Igarashi T, et al. Efficacy and safety of immunization for pre- and post- liver transplant children. Transplantation 2002; 74:543-50; PMID:12352917; http://dx.doi.org/10.1097/00007890-200208270-00020
   PubMed Web of Science ®Google Scholar
• Loinaz C, de Juanes JR, Gonzalez EM, Lopez A, Lumbreras C, Gomez R, Gonzalez-Pinto I, Jimenez C, Garcia I, Fuertes A. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997; 44:235-8; PMID:9058151
   PubMed Web of Science ®Google Scholar
• Shinjoh M, Miyairi I, Hoshino K, Takahashi T, Nakayama T. Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine 2008; 26:6859-63; PMID:18930096; http://dx.doi.org/10.1016/j.vaccine.2008.09.076
   PubMed Web of Science ®Google Scholar
• Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 1997; 99:35-9; PMID:8989334; http://dx.doi.org/10.1542/peds.99.1.35
   PubMed Web of Science ®Google Scholar
• Warmington L, Lee BE, Robinson JL. Loss of antibodies to measles and varicella following solid organ transplantation in children. Pediatr Transplant 2005; 9:311-4; PMID:15910386; http://dx.doi.org/10.1111/j.1399-3046.2005.00313.x
   PubMed Web of Science ®Google Scholar
• Gunther M, Neuhaus R, Bauer T, Jilg W, Holtz JA, Bienzle U. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine. Liver Transpl 2006; 12:316-9; PMID:16447191; http://dx.doi.org/10.1002/lt.20674
   PubMed Web of Science ®Google Scholar
• Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001; 71:477-9; PMID:11233913; http://dx.doi.org/10.1097/00007890-200102150-00023
   PubMed Web of Science ®Google Scholar
• L'Huillier AG, Wildhaber BE, Belli DC, Diana A, Rodriguez M, Siegrist CA, Posfay-Barbe KM. Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference center. Pediatr Transplant 2012; 16:50-7; PMID:22093802; http://dx.doi.org/10.1111/j.1399-3046.2011.01600.x
   PubMed Web of Science ®Google Scholar
• Horlander JC, Boyle N, Manam R, Schenk M, Herring S, Kwo PY, Lumeng L, Chalasani N. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci 1999; 318:304-7; PMID:10555092; http://dx.doi.org/10.1097/00000441-199911000-00004
   PubMed Web of Science ®Google Scholar
• Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl 2001; 7:314-20; PMID:11303291; http://dx.doi.org/10.1053/jlts.2001.23069
   PubMed Web of Science ®Google Scholar
• Leung DH, Ton-That M, Economides JM, Healy CM. High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients. Am J Transplant 2015; 15:535-40; PMID:25611886; http://dx.doi.org/10.1111/ajt.12987
   PubMed Web of Science ®Google Scholar
• Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarstrom L, Lonnqvist B, Paulin T, Ringden O, Pepe MS, Gahrton G. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162:496-500; PMID:2197342; http://dx.doi.org/10.1093/infdis/162.2.496
   PubMed Web of Science ®Google Scholar
• Stark K, Gunther M, Schonfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 2002; 359:957-65; PMID:11918932; http://dx.doi.org/10.1016/S0140-6736(02)08028-5
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62; PMID:20689501
   PubMedGoogle Scholar
• Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med 2010; 363:2036-44; PMID:21083388; http://dx.doi.org/10.1056/NEJMra1002842
   PubMed Web of Science ®Google Scholar
• Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec 2014; 89:93-104; PMID:24707514
   PubMedGoogle Scholar
• Kumar D, Husain S, Chen MH, Moussa G, Himsworth D, Manuel O, Studer S, Pakstis D, McCurry K, Doucette K, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010; 89:1028-33; PMID:20075787; http://dx.doi.org/10.1097/TP.0b013e3181d05a71
   PubMed Web of Science ®Google Scholar
• Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. The Lancet Infectious diseases 2010; 10:521-6; PMID:20620116; http://dx.doi.org/10.1016/S1473-3099(10)70133-X
   PubMed Web of Science ®Google Scholar
• Ison MG. Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses 2013; 7 Suppl 3:60-6; PMID:24215383; http://dx.doi.org/10.1111/irv.12170
   PubMed Web of Science ®Google Scholar
• Kumar D, Blumberg EA, Danziger-Isakov L, Kotton CN, Halasa NB, Ison MG, Avery RK, Green M, Allen UD, Edwards KM, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant 2011; 11:2020-30; PMID:21957936; http://dx.doi.org/10.1111/j.1600-6143.2011.03753.x
   PubMed Web of Science ®Google Scholar
• Kumar D, Morris MI, Kotton CN, Fischer SA, Michaels MG, Allen U, Blumberg EA, Green M, Humar A, Ison MG, et al. Guidance on Novel Influenza A/H1N1 in Solid Organ Transplant Recipients†. American Journal of Transplantation 2010; 10:18-25; PMID:19958321; http://dx.doi.org/10.1111/j.1600-6143.2009.02960.x
   PubMed Web of Science ®Google Scholar
• KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 Suppl 3:S1-155
   PubMed Web of Science ®Google Scholar
• Baluch A, Humar A, Eurich D, Egli A, Liacini A, Hoschler K, Campbell P, Berka N, Urschel S, Wilson L, et al. Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. Am J Transplant 2013; 13:1026-33; PMID:23406320; http://dx.doi.org/10.1111/ajt.12149
   PubMed Web of Science ®Google Scholar
• Birdwell KA, Ikizler MR, Sannella EC, Wang L, Byrne DW, Ikizler TA, Wright PF. Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis 2009; 54:112-21; PMID:19185404; http://dx.doi.org/10.1053/j.ajkd.2008.09.023
   PubMed Web of Science ®Google Scholar
• Manuel O, Humar A, Berutto C, Ely L, Giulieri S, Lien D, Meylan PR, Weinkauf J, Pascual M, Nador R, et al. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant 2011; 30:679-84; PMID:21377898; http://dx.doi.org/10.1016/j.healun.2011.01.705
   PubMed Web of Science ®Google Scholar
• Manuel O, Humar A, Chen MH, Chernenko S, Singer LG, Cobos I, Kumar D. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 2007; 7:2567-72; PMID:17908277; http://dx.doi.org/10.1111/j.1600-6143.2007.01982.x
   PubMed Web of Science ®Google Scholar
• Scharpe J, Evenepoel P, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Peetermans WE. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8:332-7; PMID:18162092; http://dx.doi.org/10.1111/j.1600-6143.2007.02066.x
   PubMed Web of Science ®Google Scholar
• Kumar D, Campbell P, Hidalgo L, Hoschler K, Al-Dabbagh M, Humar A. Randomized Trial of a MF59 Adjuvanted Influenza Vaccine in Kidney Transplant Recipients. World Transplant Congress. San Francisco, USA, 2014.
   Google Scholar
• GiaQuinta S, Michaels MG, McCullers JA, Wang L, Fonnesbeck C, O'Shea A, Green M, Halasa NB. Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients. Pediatr Transplant 2015; 19:219-28; PMID:25523718; http://dx.doi.org/10.1111/petr.12419
   PubMed Web of Science ®Google Scholar
• Candon S, Thervet E, Lebon P, Suberbielle C, Zuber J, Lima C, Charron D, Legendre C, Chatenoud L. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009; 9:2346-54; PMID:19656126; http://dx.doi.org/10.1111/j.1600-6143.2009.02787.x
   PubMed Web of Science ®Google Scholar
• Vermeiren P, Aubert V, Sugamele R, Aubert JD, Venetz JP, Meylan P, Pascual M, Manuel O. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transpl Int 2014; 27:903-8; PMID:24797932; http://dx.doi.org/10.1111/tri.12345
   PubMed Web of Science ®Google Scholar
• Fairhead T, Hendren E, Tinckam K, Rose C, Sherlock CH, Shi L, Crowcroft NS, Gubbay JB, Landsberg D, Knoll G, et al. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. Transpl Infect Dis 2012; 14:575-83; PMID:22999005; http://dx.doi.org/10.1111/tid.12006
   PubMed Web of Science ®Google Scholar
• Katerinis I, Hadaya K, Duquesnoy R, Ferrari-Lacraz S, Meier S, van Delden C, Martin PY, Siegrist CA, Villard J. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 2011; 11:1727-33; PMID:21672157; http://dx.doi.org/10.1111/j.1600-6143.2011.03604.x
   PubMed Web of Science ®Google Scholar
• L'Huillier AG, Posfay Barbe K. Live viral vaccines in transplanted patients. Swiss Med Wkly 2014; 144:w14005; PMID:25341637
   PubMedGoogle Scholar
• Barria MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM. Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis 2013; 207:115-24; PMID:23087433; http://dx.doi.org/10.1093/infdis/jis641
   PubMed Web of Science ®Google Scholar
• Boyce TG, Gruber WC, Coleman-Dockery SD, Sannella EC, Reed GW, Wolff M, Wright PF. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 1999; 18:82-8; PMID:10501238; http://dx.doi.org/10.1016/S0264-410X(99)00183-8
   PubMed Web of Science ®Google Scholar
• Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Vaccine 2009; 27:1101-10; PMID:19095024; http://dx.doi.org/10.1016/j.vaccine.2008.11.093
   PubMed Web of Science ®Google Scholar
• Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-96; PMID:17301299; http://dx.doi.org/10.1056/NEJMoa065368
   PubMed Web of Science ®Google Scholar
• Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000; 136:168-75; PMID:10657821; http://dx.doi.org/10.1016/S0022-3476(00)70097-7
   PubMed Web of Science ®Google Scholar
• Levin MJ, Song LY, Fenton T, Nachman S, Patterson J, Walker R, Kemble G, Allende M, Hultquist M, Yi T, et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine 2008; 26:4210-7; PMID:18597900; http://dx.doi.org/10.1016/j.vaccine.2008.05.054
   PubMed Web of Science ®Google Scholar
• Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, et al. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis 2011; 204:1475-82; PMID:21949042; http://dx.doi.org/10.1093/infdis/jir561
   PubMed Web of Science ®Google Scholar
• Kussmaul SC, Horn BN, Dvorak CC, Abramovitz L, Cowan MJ, Weintrub PS. Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs. Bone Marrow Transplant 2010; 45:1602-6; PMID:20190839; http://dx.doi.org/10.1038/bmt.2010.31
   PubMed Web of Science ®Google Scholar
• Kumar D, Humar A, Plevneshi A, Green K, Prasad GV, Siegal D, McGeer A. Invasive pneumococcal disease in solid organ transplant recipients–10-year prospective population surveillance. Am J Transplant 2007; 7:1209-14; PMID:17286615; http://dx.doi.org/10.1111/j.1600-6143.2006.01705.x
   PubMed Web of Science ®Google Scholar
• Pneumococcal vaccines WHO position paper–2012. Wkly Epidemiol Rec 2012; 87:129-44; PMID:24340399
   PubMedGoogle Scholar
• Clutterbuck EA, Lazarus R, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, et al. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis 2012; 205:1408-16; PMID:22457293; http://dx.doi.org/10.1093/infdis/jis212
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011; 11:760-8; PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1
   PubMed Web of Science ®Google Scholar
• Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32-41; PMID:19947881; http://dx.doi.org/10.1086/648593
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF, Huppler Hullsiek K, Roediger M, Ganesan A, Patel S, Landrum ML, Weintrob A, Agan BK, Medina S, Rahkola J, et al. A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults. J Infect Dis 2010; 202:1114-25; PMID:20795819; http://dx.doi.org/10.1086/656147
   PubMed Web of Science ®Google Scholar
• Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, et al. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults. Vaccine 2001; 20:545-53; PMID:11672921; http://dx.doi.org/10.1016/S0264-410X(01)00347-4
   PubMed Web of Science ®Google Scholar
• French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, Longwe H, Mwaiponya M, Zijlstra EE, Molyneux ME, Gilks CF. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010; 362:812-22; PMID:20200385; http://dx.doi.org/10.1056/NEJMoa0903029
   PubMed Web of Science ®Google Scholar
• French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355:2106-11; PMID:10902624; http://dx.doi.org/10.1016/S0140-6736(00)02377-1
   PubMed Web of Science ®Google Scholar
• Kotton CN, Hibberd PL, Practice ASTIDCo. Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant 2013; 13 Suppl 4:337-47; PMID:23465026; http://dx.doi.org/10.1111/ajt.12125
   PubMed Web of Science ®Google Scholar
• Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816-9; PMID:23051612
   PubMedGoogle Scholar
• Stark K, Gunther M, Neuhaus R, Reinke P, Schroder K, Linnig S, Bienzle U. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999; 180:2014-7; PMID:10558960; http://dx.doi.org/10.1086/315125
   PubMed Web of Science ®Google Scholar
• Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001; 72:272-6; PMID:11477352; http://dx.doi.org/10.1097/00007890-200107270-00019
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Ro H, Jeong JC, Koo TY, Han M, Min SI, Oh KH, Ha J, Ahn C, Yang J. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis 2014; 16:511-5; PMID:24750343; http://dx.doi.org/10.1111/tid.12217
   PubMed Web of Science ®Google Scholar
• Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, et al. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant 2015; 15:1162-72; PMID:25707744; http://dx.doi.org/10.1111/ajt.13187
   PubMed Web of Science ®Google Scholar
• Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol 1990; 85:1590-2; PMID:2252022
   PubMed Web of Science ®Google Scholar
• Duca P, Del Pont JM, D'Agostino D. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation. J Pediatr Gastroenterol Nutr 2001; 32:168-70; PMID:11321387; http://dx.doi.org/10.1097/00005176-200102000-00014
   PubMed Web of Science ®Google Scholar
• Feldhoff CM, Balfour HH, Jr., Simmons RL, Najarian JS, Mauer SM. Varicella in children with renal transplants. J Pediatr 1981; 98:25-31; PMID:7005416; http://dx.doi.org/10.1016/S0022-3476(81)80527-6
   PubMed Web of Science ®Google Scholar
• Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics 1992; 90:216-20; PMID:1322522
   PubMed Web of Science ®Google Scholar
• Takahashi M, Okuno Y, Otsuka T, Osame J, Takamizawa A. Development of a live attenuated varicella vaccine. Biken J 1975; 18:25-33; PMID:167707
   PubMedGoogle Scholar
• Andre FE. Worldwide experience with the Oka-strain live varicella vaccine. Postgrad Med J 1985; 61 Suppl 4:113-20; PMID:3014468
   PubMed Web of Science ®Google Scholar
• Mizuta K, Urahashi T, Ihara Y, Sanada Y, Wakiya T, Yamada N, Okada N, Egami S, Kawarasaki H. Varicella zoster virus disease after pediatric living donor liver transplantation: is it serious? Transplant Proc 2012; 44:780-3; PMID:22483494; http://dx.doi.org/10.1016/j.transproceed.2012.01.009
   PubMed Web of Science ®Google Scholar
• Pergam SA, Limaye AP, Practice ASTIDCo. Varicella zoster virus (VZV) in solid organ transplant recipients. Am J Transplant 2009; 9 Suppl 4:S108-15; PMID:20070670; http://dx.doi.org/10.1111/j.1600-6143.2009.02901.x
   PubMedGoogle Scholar
• Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994; 8:190-2; PMID:8018498; http://dx.doi.org/10.1007/BF00865476
   PubMed Web of Science ®Google Scholar
• Khan S, Erlichman J, Rand EB. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant 2006; 10:78-82; PMID:16499592; http://dx.doi.org/10.1111/j.1399-3046.2005.00403.x
   PubMed Web of Science ®Google Scholar
• Chaves Tdo S, Lopes MH, de Souza VA, Dos Santos Sde S, Pereira LM, Reis AD, David-Neto E. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplant 2005; 9:192-6; PMID:15787792; http://dx.doi.org/10.1111/j.1399-3046.2005.00279.x
   PubMed Web of Science ®Google Scholar
• Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL, Kochanowicz S, Seipel KR, Levin MJ. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006; 6:565-8; PMID:16468967; http://dx.doi.org/10.1111/j.1600-6143.2005.01210.x
   PubMed Web of Science ®Google Scholar
• Posfay-Barbe KM, Pittet LF, Sottas C, Grillet S, Wildhaber BE, Rodriguez M, Kaiser L, Belli DC, McLin VA, Siegrist CA. Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic. Am J Transplant 2012; 12:2974-85; PMID:22994936; http://dx.doi.org/10.1111/j.1600-6143.2012.04273.x
   PubMed Web of Science ®Google Scholar
• Tang H, Moriishi E, Okamoto S, Okuno Y, Iso H, Asada H, Yamanishi K, Mori Y. A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J Clin Virol 2012; 55:46-50; PMID:22771002; http://dx.doi.org/10.1016/j.jcv.2012.06.008
   PubMed Web of Science ®Google Scholar
• Prelog M, Schonlaub J, Jeller V, Almanzar G, Hofner K, Gruber S, Eiwegger T, Wurzner R. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients. Vaccine 2013; 31:2420-6; PMID:23583889; http://dx.doi.org/10.1016/j.vaccine.2013.03.058
   PubMed Web of Science ®Google Scholar
• Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004; 4:108-15; PMID:14678041; http://dx.doi.org/10.1046/j.1600-6143.2003.00287.x
   PubMed Web of Science ®Google Scholar
• Manuel O, Kumar D, Singer LG, Cobos I, Humar A. Incidence and clinical characteristics of herpes zoster after lung transplantation. J Heart Lung Transplant 2008; 27:11-6; PMID:18187081; http://dx.doi.org/10.1016/j.healun.2007.09.028
   PubMed Web of Science ®Google Scholar
• Weaver BA. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine. J Am Osteopath Assoc 2011; 111:S31-3; PMID:22086893
   PubMedGoogle Scholar
• Gastanaduy PA, Redd SB, Fiebelkorn AP, Rota JS, Rota PA, Bellini WJ, Seward JF, Wallace GS, Division of Viral Disease NCfI, Respiratory Diseases CDC. Measles - United States, January 1-May 23, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:496-9; PMID:24898167
   PubMed Web of Science ®Google Scholar
• Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis. Adv Perit Dial 1999; 15:269-72; PMID:10682116
   PubMedGoogle Scholar
• Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol 1992; 6:187-9; PMID:1571219; http://dx.doi.org/10.1007/BF00866312
   PubMed Web of Science ®Google Scholar
• Mori K, Kawamura K, Honda M, Sasaki N. Responses in children to measles vaccination associated with perirenal transplantation. Pediatr Int 2009; 51:617-20; PMID:19438829; http://dx.doi.org/10.1111/j.1442-200X.2009.02816.x
   PubMed Web of Science ®Google Scholar
• Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993; 123:87-9; PMID:8320632; http://dx.doi.org/10.1016/S0022-3476(05)81545-8
   PubMed Web of Science ®Google Scholar
• Kwak EJ, Julian K. Human papillomavirus infection in solid organ transplant recipients. Am J Transplant 2009; 9 Suppl 4:S151-60; PMID:20070675; http://dx.doi.org/10.1111/j.1600-6143.2009.02906.x
   PubMedGoogle Scholar
• Gomez-Lobo V, Whyte T, Kaufman S, Torres C, Moudgil A. Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients. Pediatr Transplant 2014; 18:310-5; PMID:24484551; http://dx.doi.org/10.1111/petr.12226
   PubMed Web of Science ®Google Scholar
• Kumar D, Unger ER, Panicker G, Medvedev P, Wilson L, Humar A. Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant 2013; 13:2411-7; PMID:23837399; http://dx.doi.org/10.1111/ajt.12329
   PubMed Web of Science ®Google Scholar
• Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec 2013; 88:49-64; PMID:23424730
   PubMedGoogle Scholar
• Hsieh YC, Wu FT, Hsiung CA, Wu HS, Chang KY, Huang YC. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine. Vaccine 2014; 32:1199-204; PMID:24076325; http://dx.doi.org/10.1016/j.vaccine.2013.08.041
   PubMed Web of Science ®Google Scholar
• Markkula J, Hemming M, Vesikari T. Detection of vaccine-derived rotavirus strains in nonimmunocompromised children up to 3–6 months after RotaTeq(R) vaccination. Pediatr Infect Dis J 2015; 34:296-8; PMID:25260041; http://dx.doi.org/10.1097/INF.0000000000000579
   PubMed Web of Science ®Google Scholar
• Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143-238; PMID:19747629; http://dx.doi.org/10.1016/j.bbmt.2009.06.019
   PubMed Web of Science ®Google Scholar
• Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J, Small T, Center for International B, Marrow Transplant R, National Marrow Donor P, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44:521-6; PMID:19861986; http://dx.doi.org/10.1038/bmt.2009.263
   PubMed Web of Science ®Google Scholar
• Lum LG, Munn NA, Schanfield MS, Storb R. The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood 1986; 67:582-7; PMID:3511982
   PubMed Web of Science ®Google Scholar
• Lum LG, Noges JE, Beatty P, Martin PJ, Deeg J, Doney KC, Loughran T, Sullivan KM, Witherspoon RP, Thomas ED, et al. Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts. Bone Marrow Transplant 1988; 3:399-406; PMID:3056548
   PubMed Web of Science ®Google Scholar
• Wimperis JZ, Brenner MK, Prentice HG, Reittie JE, Karayiannis P, Griffiths PD, Hoffbrand AV. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet 1986; 1:339-43; PMID:2868294; http://dx.doi.org/10.1016/S0140-6736(86)92315-9
   PubMed Web of Science ®Google Scholar
• Molrine DC, Guinan EC, Antin JH, Parsons SK, Weinstein HJ, Wheeler C, McGarigle C, Blanding P, Phillips NR, Kinsella K, et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87:3012-8; PMID:8639924
   PubMed Web of Science ®Google Scholar
• Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R, Malinoski F, Trocciola S, Wilson M, Ambrosino DM. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101:831-6; PMID:12393732; http://dx.doi.org/10.1182/blood-2002-03-0832
   PubMed Web of Science ®Google Scholar
• Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K, McGeer A. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 2008; 41:743-7; PMID:18176614; http://dx.doi.org/10.1038/sj.bmt.1705964
   PubMed Web of Science ®Google Scholar
• Kumar D, Chen MH, Welsh B, Siegal D, Cobos I, Messner HA, Lipton J, Humar A. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 2007; 45:1576-82; PMID:18190318; http://dx.doi.org/10.1086/523583
   PubMed Web of Science ®Google Scholar
• Patel SR, Ortin M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis 2007; 44:625-34; PMID:17278051; http://dx.doi.org/10.1086/511641
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Ljungman P, Juergens C, Maertens J, Selleslag D, Sundaraiyer V, Giardina PC, Clarke K, Gruber WC, Scott DA, et al. Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged >/=2 Years: an open-label study. Clin Infect Dis 2015; ;61(3):313-23; PMID:25870329
   PubMed Web of Science ®Google Scholar
• Jaffe D, Papadopoulos EB, Young JW, O'Reilly RJ, Prockop S, Kernan NA, Jakubowski A, Boulad F, Perales MA, Castro-Malaspina H, et al. Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood 2006; 108:2470-5; PMID:16763208; http://dx.doi.org/10.1182/blood-2006-04-006981
   PubMed Web of Science ®Google Scholar
• Machado CM. Reimmunization after bone marrow transplantation–current recommendations and perspectives. Braz J Med Biol Res 2004; 37:151-8; PMID:14689057; http://dx.doi.org/10.1590/S0100-879X2004000100021
   PubMed Web of Science ®Google Scholar
• Li Volti S, Di Gregorio F, Romeo MA, Cannella A, Pizzarelli G, Sciacca A, Russo G. Immune status and the immune response to hepatitis B virus vaccine in thalassemic patients after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19:157-60; PMID:9116613; http://dx.doi.org/10.1038/sj.bmt.1700635
   PubMed Web of Science ®Google Scholar
• Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 25:167-72; PMID:10673675; http://dx.doi.org/10.1038/sj.bmt.1702119
   PubMed Web of Science ®Google Scholar
• Chou JF, Kernan NA, Prockop S, Heller G, Scaradavou A, Kobos R, Knowles MA, Papadopoulos EB, Casson A, Copeland C, et al. Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant 2011; 17:1708-13; PMID:21664979; http://dx.doi.org/10.1016/j.bbmt.2011.05.006
   PubMed Web of Science ®Google Scholar
• Sasadeusz J, Prince HM, Schwarer A, Szer J, Stork A, Bock HL, Povey M, Nicholson O, Innis BL. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation. Transpl Infect Dis 2014; 16(6):1024-31; PMID:25272081
   PubMed Web of Science ®Google Scholar
• Ljungman P, Wang FZ, Nilsson C, Solheim V, Linde A. Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study. Support Care Cancer 2003; 11:739-41; PMID:13680325; http://dx.doi.org/10.1007/s00520-003-0527-8
   PubMed Web of Science ®Google Scholar
• Issa NC, Marty FM, Leblebjian H, Galar A, Shea MM, Antin JH, Soiffer RJ, Baden LR. Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2014; 20:285-7; PMID:24269706; http://dx.doi.org/10.1016/j.bbmt.2013.11.013
   PubMed Web of Science ®Google Scholar
• Naidus E, Damon L, Schwartz BS, Breed C, Liu C. Experience with use of Zostavax((R)) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Am J Hematol 2012; 87:123-5; PMID:22052650; http://dx.doi.org/10.1002/ajh.22196
   PubMed Web of Science ®Google Scholar
• Stadtmauer EA, Sullivan KM, Marty FM, Dadwal SS, Papanicolaou GA, Shea TC, Mossad SB, Andreadis C, Young JA, Buadi FK, et al. A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood 2014; 124:2921-9; PMID:25237196; http://dx.doi.org/10.1182/blood-2014-04-573048
   PubMed Web of Science ®Google Scholar
• Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane MR, Stek JE, Sterling TM, et al. Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults. J Infect Dis 2013; 208:1375-85; PMID:23908479; http://dx.doi.org/10.1093/infdis/jit344
   PubMed Web of Science ®Google Scholar
• Redman RL, Nader S, Zerboni L, Liu C, Wong RM, Brown BW, Arvin AM. Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis 1997; 176:578-85; PMID:9291302; http://dx.doi.org/10.1086/514077
   PubMed Web of Science ®Google Scholar
• Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002; 347:26-34; PMID:12097537; http://dx.doi.org/10.1056/NEJMoa013441
   PubMed Web of Science ®Google Scholar
• Pauksen K, Duraj V, Ljungman P, Sjolin J, Oberg G, Lonnerholm G, Fridell E, Smedmyr B, Simonsson B. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9:427-32; PMID:1628126
   PubMed Web of Science ®Google Scholar
• Ljungman P, Fridell E, Lonnqvist B, Bolme P, Bottiger M, Gahrton G, Linde A, Ringden O, Wahren B. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159:610-5; PMID:2647859; http://dx.doi.org/10.1093/infdis/159.4.610
   PubMed Web of Science ®Google Scholar
• Machado CM, de Souza VA, Sumita LM, da Rocha IF, Dulley FL, Pannuti CS. Early measles vaccination in bone marrow transplant recipients. Bone Marrow Transplant 2005; 35:787-91; PMID:15750610; http://dx.doi.org/10.1038/sj.bmt.1704878
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Bleakley M, Burgess M. Safety of early immunization against measles/mumps/rubella after bone marrow transplantation. Blood 2002; 99:3486; PMID:12001909; http://dx.doi.org/10.1182/blood-2002-01-0212
   PubMed Web of Science ®Google Scholar
• Machado CM. Reimmunization after hematopoietic stem cell transplantation. Expert Rev Vaccines 2005; 4:219-28; PMID:15889995; http://dx.doi.org/10.1586/14760584.4.2.219
   PubMed Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62:1-28; PMID:23515099
   PubMed Web of Science ®Google Scholar
• Diana A, Posfay-Barbe KM, Belli DC, Siegrist CA. Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference center. Pediatr Transplant 2007; 11:31-7; PMID:17239121; http://dx.doi.org/10.1111/j.1399-3046.2006.00596.x
   PubMed Web of Science ®Google Scholar
• Prevots DR, Burr RK, Sutter RW, Murphy TV, Advisory Committee on Immunization P. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000; 49:1-22; quiz CE1-7
   PubMedGoogle Scholar
• Who. Polio vaccines: WHO position paper, January 2014–recommendations. Vaccine 2014; 32:4117-8; PMID:24768729; http://dx.doi.org/10.1016/j.vaccine.2014.04.023
   PubMed Web of Science ®Google Scholar
• Staples JE, Gershman M, Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59:1-27
   PubMedGoogle Scholar
• Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D, et al. Persistence of Yellow Fever Vaccine–Induced Antibodies After Solid Organ Transplantation. Am J Transplant 2013; 13:2458-61; PMID:23834702; http://dx.doi.org/10.1111/ajt.12338
   PubMed Web of Science ®Google Scholar
• Azevedo LS, Lasmar EP, Contieri FL, Boin I, Percegona L, Saber LT, Selistre LS, Netto MV, Moreira MC, Carvalho RM, et al. Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study. Transpl Infect Dis 2012; 14:237-41; PMID:22093046; http://dx.doi.org/10.1111/j.1399-3062.2011.00686.x
   PubMed Web of Science ®Google Scholar
• Yun SI, Lee YM. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother 2014; 10:263-79; PMID:24161909; http://dx.doi.org/10.4161/hv.26902
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Wattanatitan S, Techasaensiri C, Yoksan S, Sirireung S, Hongeng S. Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation. Bone Marrow Transplant 2014; 49:1307-9; PMID:25046215; http://dx.doi.org/10.1038/bmt.2014.149
   PubMed Web of Science ®Google Scholar
• Jelinek T, Kollaritsch H. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera. Expert Rev Vaccines 2008; 7:561-7; PMID:18564011; http://dx.doi.org/10.1586/14760584.7.5.561
   PubMed Web of Science ®Google Scholar
• Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, Khan AI, Khan IA, Clemens J, Ali M, Cravioto A, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine 2011; 29:8285-92; PMID:21907255; http://dx.doi.org/10.1016/j.vaccine.2011.08.108
   PubMed Web of Science ®Google Scholar
• Pass RF, Duliege AM, Boppana S, Sekulovich R, Percell S, Britt W, Burke RL. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis 1999; 180:970-5; PMID:10479120; http://dx.doi.org/10.1086/315022
   PubMed Web of Science ®Google Scholar
• Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360:1191-9; PMID:19297572; http://dx.doi.org/10.1056/NEJMoa0804749
   PubMed Web of Science ®Google Scholar
• Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, et al. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 2011; 377:1256-63; PMID:21481708; http://dx.doi.org/10.1016/S0140-6736(11)60136-0
   PubMed Web of Science ®Google Scholar
• Wloch MK, Smith LR, Boutsaboualoy S, Reyes L, Han C, Kehler J, Smith HD, Selk L, Nakamura R, Brown JM, et al. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J Infect Dis 2008; 197:1634-42; PMID:18444883; http://dx.doi.org/10.1086/588385
   PubMed Web of Science ®Google Scholar
• Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 2012; 12:290-9; PMID:22237175; http://dx.doi.org/10.1016/S1473-3099(11)70344-9
   PubMed Web of Science ®Google Scholar
• Kharfan-Dabaja MA, Nishihori T. Vaccine therapy for cytomegalovirus in the setting of allogeneic hematopoietic cell transplantation. Expert Rev Vaccines 2015; 14:341-50; PMID:25468066; http://dx.doi.org/10.1586/14760584.2015.989990
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Starr SE, Friedman HM, Brayman K, Harris S, Jackson S, Tustin NB, Grossman R, Dafoe D, Barker C. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med 1991; 114:525-31; PMID:1848053; http://dx.doi.org/10.7326/0003-4819-114-7-525
   PubMed Web of Science ®Google Scholar